{"id":75995,"date":"2018-02-14T17:42:42","date_gmt":"2018-02-15T01:42:42","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/02\/trial-shows-canakinumab-prevents-cancer-and-heart-attacks"},"modified":"2018-02-14T17:42:42","modified_gmt":"2018-02-15T01:42:42","slug":"trial-shows-canakinumab-prevents-cancer-and-heart-attacks","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/02\/trial-shows-canakinumab-prevents-cancer-and-heart-attacks","title":{"rendered":"Trial Shows Canakinumab Prevents Cancer and Heart Attacks"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/trial-shows-canakinumab-prevents-cancer-and-heart-attacks.jpg\"><\/a><\/p>\n<p>Doctors implicate chronic inflammation as a cause of heart disease and cancer with some claiming that reducing persistent, low-grade inflammation will reduce these diseases. In fact, a recent clinical trial discovered that the inflammation-lowering drug Canakinumab reduced heart attack and strokes by nearly a fourth and cancer by about half.<\/p>\n<p>More than ever, physicians believe that reducing chronic inflammation will also reduce heart attacks and strokes. Robert A. Harrington, M.D., a Cardiologist with the Department of Medicine at Stanford University, leans toward the inflammatory hypothesis of heart disease, a belief that chronic inflammation is a significant cause of heart disease. According to Dr. Harrington.<\/p>\n<blockquote><p>\u201cInflammatory cells and signals drive the healing response to vascular injury, allowing the initiation and growth of atherosclerotic plaque.\u201d<\/p><\/blockquote>\n<p><!-- Link: <a href=\"http:\/\/longevityfacts.com\/prevent-preventing-chronic-inflammation-stop-cancer-heart-attacks-stroke\/\">http:\/\/longevityfacts.com\/prevent-preventing-chronic-inflamm...ks-stroke\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Doctors implicate chronic inflammation as a cause of heart disease and cancer with some claiming that reducing persistent, low-grade inflammation will reduce these diseases. In fact, a recent clinical trial discovered that the inflammation-lowering drug Canakinumab reduced heart attack and strokes by nearly a fourth and cancer by about half. More than ever, physicians believe [\u2026]<\/p>\n","protected":false},"author":446,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-75995","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/75995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/446"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=75995"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/75995\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=75995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=75995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=75995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}